Seong Hoon Yoon

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations

J. Son, Ji-Hye Park, Jun-Yong Choi, 2020, Medicine.

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Chang-Min Choi, J. Lim, Sung-Yong Lee, 2024, Cancers.